CTRI/2020/05/025289尚未招募未知
An observational study on Hydroxychloroquine used as prophylaxis for high COVID exposure risk individuals with special reference to QT interval
P Vamsavardhana Reddy0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •All High COVID exposure risk individuals aged above 18 years & weight > 35 kg consuming Hydroxychloroquine as prophylaxis for COVID-19
排除标准
- •Individuals not willing to participate in the study
研究者
相似试验
进行中（未招募）
1 期
Trial of hydroxychloroquine in the treatment of adult patients with Covid-19 infection in a primary care settingCovid-19 infectionEUCTR2020-002038-33-FIPorin kaupunki600
进行中（未招募）
1 期
Randomized controlled trial of hydroxychloroquine versus placebo in early ambulatory diagnosis and treatment of elderly COVID-19 PatientsCoronavirus diseaseEUCTR2020-001482-37-DEniversity Hopsital Tuebingen350
进行中（未招募）
1 期
Systematic study of the medicine hydroxychloroquine against placebo for the treatment of adult patients with acute coronavirus disease 2019 – COVID-19Acute coronavirus disease 2019MedDRA version: 20.1Level: PTClassification code 10053983Term: Corona virus infectionSystem Organ Class: 10021881 - Infections and infestationsEUCTR2020-001224-33-DEniversitätsklinikum Tübingen220
已完成
不适用
A randomized controlled trial of hydroxychloroquine prophylaxis for Healthcare Workers exposed to COVID-19CTRI/2020/05/025067George Institute for Global Health India416
尚未招募
3 期
Efficacy of hydroxychloroquine in graves disease in addition to antithyroid drugs.CTRI/2023/07/054894IPQA laboratories